__timestamp | Galapagos NV | Teva Pharmaceutical Industries Limited |
---|---|---|
Wednesday, January 1, 2014 | 111110000 | 9216000000 |
Thursday, January 1, 2015 | 129714000 | 8296000000 |
Friday, January 1, 2016 | 139574000 | 10044000000 |
Sunday, January 1, 2017 | 218502000 | 11560000000 |
Monday, January 1, 2018 | 322876000 | 10558000000 |
Tuesday, January 1, 2019 | 427320000 | 9351000000 |
Wednesday, January 1, 2020 | 523667000 | 8933000000 |
Friday, January 1, 2021 | 1629000 | 8284000000 |
Saturday, January 1, 2022 | 12079000 | 7952000000 |
Sunday, January 1, 2023 | 35989000 | 8200000000 |
Monday, January 1, 2024 | 8480000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, cost management is crucial for sustaining growth and innovation. This analysis compares the cost of revenue for Teva Pharmaceutical Industries Limited and Galapagos NV from 2014 to 2023. Over this period, Teva's cost of revenue consistently dwarfed that of Galapagos, averaging around 9.2 billion annually, while Galapagos averaged a modest 192 million.
Teva's cost of revenue peaked in 2017 at approximately 11.6 billion, reflecting its expansive operations and market reach. In contrast, Galapagos saw its highest cost in 2020, with a 523% increase from 2014, highlighting its growth trajectory. However, the data also reveals a significant drop in Galapagos' costs in 2021, indicating potential strategic shifts or operational efficiencies.
This comparison underscores the diverse financial strategies within the pharmaceutical sector, offering insights into how companies navigate market challenges.
Cost Insights: Breaking Down Amgen Inc. and Teva Pharmaceutical Industries Limited's Expenses
Cost Insights: Breaking Down Sanofi and Galapagos NV's Expenses
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and ADMA Biologics, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Viridian Therapeutics, Inc.'s Expenses